Key result
High-risk patients presenting with syncope had a significantly higher mortality rate compared to low-risk patients (3.99%/year vs. 1.02%/year; P=0.02), independent of the presence of ischemia.
Why the study?
Does the presence of ischemia on stress echocardiography predict long-term mortality in patients presenting with syncope?
Cohort (n=225)
No
Does the presence of ischemia on stress echocardiography predict long-term mortality in patients presenting with syncope?
In patients presenting with syncope, high-risk clinical features predict mortality, whereas the presence of ischemia on stress echocardiography does not appear to be predictive of long-term outcomes.
High-risk features may stratify mortality risk in syncope; leaves open whether ischemia on stress echocardiography adds prognostic value.
BACKGROUND: Evaluation for ischemia is appropriate in patients at risk for or with a history of coronary artery disease presenting with syncope. The aim of this study is to determine the prognostic value of stress echocardiography in patients presenting with syncope. METHODS: We examined our database of all patients undergoing stress echocardiography at our institution. Patients referred due to syncope were grouped as high risk based on any of the following: (1) known history of coronary artery disease, (2) left ventricular ejection fraction <50%, (3) moderate or severe mitral or aortic valve regurgitation, and (4) moderate mitral or aortic valve stenosis. The main outcomes were the presence of ischemia on stress imaging and all-cause mortality using the social security death index. RESULTS: A total of 225 patients were identified; mean age was 64.3 ± 14.5 years, the mean follow-up duration was 29.2 ± 13.8 months. There were 163 patients in the low-risk group and 62 patients in the high-risk group. On imaging, 7% of the overall cohort had ischemia. The low-risk group had 5 (3%) patients with ischemia and the high-risk group had 10 patients (16%) with ischemia (P < 0.01). The mortality rate was significantly higher in the high-risk group (3.99%/year vs. 1.02%/year; P = 0.02); this difference was not affected by the presence of ischemia. CONCLUSIONS: High-risk patients with syncope as defined by appropriateness criteria and existing evidence carry a higher risk of ischemia and all-cause mortality. The presence of ischemia may not be predictive of long-term outcome in this group.
No takes yet. Share an insight, caveat, or question.
Po et al. (2015) conducted a cohort in Syncope (n=225). High-risk clinical features vs. Low-risk clinical features was evaluated on All-cause mortality (p=0.02). High-risk patients presenting with syncope had a significantly higher mortality rate compared to low-risk patients (3.99%/year vs. 1.02%/year; P=0.02), independent of the presence of ischemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: